On Oct 31, major Wall Street analysts update their ratings for $IDEX Corp (IEX.US)$, with price targets ranging from $230 to $248.
TD Cowen analyst Joseph C Giordano maintains with a buy rating, and maintains the target price at $230.
Baird analyst Michael Halloran maintains with a buy rating, and maintains the target price at $241.
Oppenheimer analyst Bryan Blair maintains with a buy rating, and maintains the target price at $238.
RBC Capital analyst Deane Dray maintains with a buy rating, and adjusts the target price from $236 to $248.
Furthermore, according to the comprehensive report, the opinions of $IDEX Corp (IEX.US)$'s main analysts recently are as follows:
Following Idex Corp.'s third-quarter earnings surpassing expectations, the company's modest 1% operating income beat and improved 2024 guidance forecasts were noted. However, the key factor contributing to the stock's 7% relief rally was the reported stabilization in the life sciences area within the Health & Science Technologies segment after a lengthy phase of destocking and underperformance.
The firm noted that Idex Corp.'s 3Q results were operationally aligned, with upside from FSDP counterbalancing downside in FMT. The company's 2024 guidance improved at the lower end, and the 4Q outlook aligns with consensus. Additionally, signs of stabilization are emerging, as indicated by daily order rates, demand commentary, and estimates, which is a positive development after a challenging time for the company.
Here are the latest investment ratings and price targets for $IDEX Corp (IEX.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
